Atovaquone ameliorate gastrointestinal Toxoplasmosis complications in a pregnancy model

@inproceedings{Oz2012AtovaquoneAG,
  title={Atovaquone ameliorate gastrointestinal Toxoplasmosis complications in a pregnancy model},
  author={Helieh S Oz and Thomas T Tobin},
  booktitle={Medical science monitor : international medical journal of experimental and clinical research},
  year={2012}
}
BACKGROUND Toxoplasma is an important source of foodborne hospitalization with no safe and effective therapy against chronic or congenital Toxopalsmosis. Atovaquone is a drug of choice but not approved for use in congenital Toxoplasmosis. We hypothesized atovaquone to be safe and effective against feto-maternal Toxoplasmosis. MATERIAL/METHODS Programmed pregnant mice were i.p. infected with 50-2400 Tachyzoites from Type II strain (clone PTG). Dams were treated daily with atovaquone or sham… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 39 references

European Multicentre Study on Congenital Toxoplasmosis (EMSCOT): Prenatal treatment for serious neurological squeal of congenital Toxoplasmosis: an observational prospective cohort study

  • M Cortina-Borja, HK Tan, M Wallon
  • PLoS Med,
  • 2010
2 Excerpts

Similar Papers

Loading similar papers…